PMC:7795856 / 158-384
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":28,"end":45},"obj":"Species"},{"id":"24","span":{"begin":47,"end":50},"obj":"Species"},{"id":"31","span":{"begin":56,"end":90},"obj":"Disease"},{"id":"32","span":{"begin":169,"end":177},"obj":"Disease"},{"id":"33","span":{"begin":178,"end":188},"obj":"Disease"},{"id":"34","span":{"begin":193,"end":199},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:10407"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:10407"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D006526"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:C000657245"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D007239"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"eptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-t"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":28,"end":37},"obj":"Phenotype"},{"id":"T3","span":{"begin":56,"end":65},"obj":"Phenotype"},{"id":"T4","span":{"begin":193,"end":199},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"eptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-t"}